Last update 01 Nov 2024

Oncoscience AG

Private Company|
ZURICH, Switzerland
|
www.oncoscienceag.com

Overview

Tags

Otorhinolaryngologic Diseases
Nervous System Diseases
Endocrinology and Metabolic Disease
Monoclonal antibody

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Endocrinology and Metabolic Disease1
Nervous System Diseases1
Neoplasms1
Top 5 Drug TypeCount
Monoclonal antibody1
Top 5 TargetCount
EGFR(Epidermal growth factor receptor erbB1)1

Related

1
Drugs associated with Oncoscience AG
Nimotuzumab
Target
EGFR
Mechanism
EGFR antagonists
Active Org.
Oncoscience GmbHOncoscience GmbH [+6]
Originator Org.
Center For Molecular ImmunologyCenter For Molecular Immunology
Active Indication
Pancreatic Cancer [+17]
Inactive Indication
Adenocarcinoma [+15]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
IN
First Approval Date11 Sep 2006
7
Clinical Trials associated with Oncoscience AG
NCT00561990 / CompletedPhase 2/3
A RANDOMIZED, MULTICENTER, PHASE IIB/IIIA STUDY OF GEMCITABINE AND THE MONOCLONAL ANTIBODY NIMOTUZUMAB (OSAG 101) VERSUS GEMCITABINE AND PLACEBO FOR THE TREATMENT OF CHEMOTHERAPY-NAIVE PATIENTS WITH LOCALLY ADVANCED OR METASTATIC PANCREATIC CANCER
NCT00753246 / CompletedPhase 3
Phase-III Study of Standard Radiotherapy Plus Concomitant and Adjuvant OSAG 101 (Theraloc®) Plus Temozolomide vs. Standard Radiotherapy Plus Concomitant and Adjuvant Temozolomide in Patient With Newly Diagnosed, Histologically Confirmed Glioblastoma Multiforme Grade IV
EUCTR2007-000338-38-DE / Not yet recruitingNot Applicable
A RANDOMIZED, MULTICENTER, PHASE IIB/IIIA STUDY OF GEMCITABINE AND THE MONOCLONAL ANTIBODY NIMOTUZUMAB (OSAG 101) VERSUS GEMCITABINE AND PLACEBO FOR THE TREAMENT OF CHEMOTHERAPY-NAIVE PATIENTS WITH LOCALLY ADVANCED OR METASTATIC PANCREATIC CANCER
100 Clinical Results associated with Oncoscience AG
Login to view more data
0 Patents (Medical) associated with Oncoscience AG
Login to view more data
100 Deals associated with Oncoscience AG
Login to view more data
100 Translational Medicine associated with Oncoscience AG
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 23 Dec 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Approved
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Nimotuzumab
 ( EGFR )		Glioma
More
Approved
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free